a Significant difference from the control group P<0.0001 b Significant difference from the EPC NSSL-TMN treated group P<0.001. Comparison of the therapeutic efficacy of EPC-based NSSL-TMN and DMPC:DPP

NIAID Data Ecosystem80

Table 2. Ustekinumab dosing, interval, levels, duration of therapy, and complications

用药监测

神经免疫疾病治疗

Ustekinumab dosing, interval, levels, duration of therapy, and complications

NIAID Data Ecosystem30

paracetamol induced gut microbiota dysbiosis

肠道菌群与药物相互作用

肠道-肝脏轴代谢

Integration of intestinal microbiota and metabolomics reveal the hepatoprotective effect of flax lignin pre-treatment on aminophenol overdose mice via gut-liver axis.

NIAID Data Ecosystem80

The publications and the different treatment arms.

生物制剂疗效

神经免疫疾病治疗

*P. placebo, DM: DMARD, ADA: adalimumab, CER: certolizumab, ETA: etanercept, GOL: golimumab, INF: infliximab, ANA: anakinra, ABA: abatacept, RIT: rituximab, TOC: tocilizumab.The publications and the d

Figshare2015-12-03 更新60

Prednisone caused the alterations in Gut microbiota

资源简介：

相关数据集